Jungova, A., M. Stork, I. Spicka, J. Radocha, J. Minarik, P. Pavlicek, J. Mihalyova, L. Pour, J. Straub, V. Maisnar, T. Pika, T. Dekojova, J. Soukup, T. Popkova, K. Mensikova, F. Sedlák, J. Pospiskova, I. Boichuk, P. Krhovska, T. Stopka, P. Jindra, T. Jelínek, Z. Knechtová, V. Capounova, V. Latal, L. Muronova, A. Heindorfer, J. Ullrychova, M. Sykora, P. Kessler, and R. Hajek. 2026. “P25 | REAL-WORLD OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA: EVIDENCE SUPPORTING BORTEZOMIB–LENALIDOMIDE–DEXAMETHASONE AS A PREFERRED REGIMEN WITHOUT ANTI-CD38 ANTIBODIES”. Haematologica 111 (s2). Pavia, Italy. https://doi.org/10.3324/haematol.2026.s2.14036.